JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $82 to $85.
July 25, 2024 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Boston Scientific and raises the price target from $82 to $85.
The Overweight rating and increased price target from a reputable analyst at JP Morgan is likely to boost investor confidence in Boston Scientific, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100